Elevated Pgp/ABCB1 levels, analysed by Western blot and quantitative solid-phase plate radioimmunoassay, were observed in 55% of 198 samples obtained from CML patients. Here, ABCB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.